CME Group (NASDAQ:CME) Price Target Raised to $206.00

CME Group (NASDAQ:CMEGet Free Report) had its price target lifted by stock analysts at JPMorgan Chase & Co. from $198.00 to $206.00 in a research note issued on Thursday, Benzinga reports. The brokerage presently has a “neutral” rating on the financial services provider’s stock. JPMorgan Chase & Co.‘s price target points to a potential downside of 2.34% from the stock’s current price.

A number of other research firms have also recently commented on CME. Rosenblatt Securities reiterated a “sell” rating and set a $187.00 price objective (up previously from $185.00) on shares of CME Group in a research report on Thursday. Argus upped their price objective on CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research report on Wednesday, March 6th. Morgan Stanley upped their price objective on CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 9th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $210.00 price target (down previously from $235.00) on shares of CME Group in a report on Friday, April 5th. Finally, Keefe, Bruyette & Woods boosted their price target on CME Group from $222.00 to $226.00 and gave the company a “market perform” rating in a report on Thursday. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $217.80.

View Our Latest Research Report on CME

CME Group Trading Down 0.8 %

NASDAQ CME opened at $210.94 on Thursday. The stock’s 50 day moving average is $214.73 and its 200 day moving average is $211.90. The firm has a market capitalization of $75.94 billion, a PE ratio of 24.00, a P/E/G ratio of 5.97 and a beta of 0.49. CME Group has a twelve month low of $175.73 and a twelve month high of $223.80. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.44 by $0.06. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The business had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.48 billion. During the same quarter in the previous year, the business earned $2.42 earnings per share. The firm’s quarterly revenue was up 3.2% compared to the same quarter last year. Research analysts forecast that CME Group will post 9.58 earnings per share for the current fiscal year.

Institutional Investors Weigh In On CME Group

Several hedge funds and other institutional investors have recently modified their holdings of the business. OFI Invest Asset Management bought a new position in CME Group in the third quarter worth approximately $25,000. Gold Investment Management Ltd. bought a new position in CME Group in the fourth quarter worth approximately $26,000. Northwest Financial Advisors bought a new position in CME Group in the fourth quarter worth approximately $28,000. Harbor Investment Advisory LLC boosted its position in CME Group by 966.7% during the 4th quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 145 shares in the last quarter. Finally, Compagnie Lombard Odier SCmA bought a new stake in CME Group during the 3rd quarter valued at $37,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Company Profile

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.